Login
Home / NUUU : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Rejuvel Bio-Sciences, Inc.

$0 +$0.00 (+9,900%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0 - $0
Market Cap
117.77K
AVG Volume
168.6K
Trailing/Forward PE
-0.03/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
020K40K60K80K13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Net Income (USD)
-4M-2M02M13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Operating Income (USD)
-600K-400K-200K013 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
EBITDA (USD)
-4M-2M02M13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Cash Flows (USD)
-300K-200K-100K013 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
EPS (USD)
-0.02-0.0100.0113 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Expenses (USD)
0200K400K600K800KSG&ACapex13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Cash & Debt (USD)
0100K200K300K400KCashLong Term DebtShort Term Debt13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Debt ratios
-0.6-0.4-0.2-00.213 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Margins
-200%-100%0%100%200%13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Return on Capital
-200%-100%0%100%13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Shares Outstanding
050M100M150M13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Book Value Per Share (USD)
-0.04-0.03-0.02-0.01013 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Total Assets (USD)
0100K200K300K400K13 Q213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q3
Employee Count
0510152012
PE Ratio
2022.52527.53032.5med 27.5Jun 15Jun 15Jul 15Jul 15Jul 15Aug 15
Free Cash Flow Yield
-1500000%-1000000%-500000%0%med -125646.9%Jan 25May 25Sep 25Jan 26May 26Sep 26
Price to Sales
00.010.020.03med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
2022.52527.53032.5med 27.01Jun 15Jun 15Jul 15Jul 15Jul 15Aug 15
Rejuvel Bio-Sciences, Inc.
NUUU
Stockpicker

Video analysis: NUUU

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.